文献速递复苏、休克与脓毒症呼吸衰竭与机械通气

实用气道复苏试验中无ICU天数与无呼吸机天数作为替代结局的评估

Assessment of intensive care unit-free and ventilator-free days as alternative outcomes in the pragmatic airway resuscitation trial.
PubMed 文献 · Resuscitation · 2022-08-05
一句话结论在OHCA试验中,无ICU天数和无呼吸机天数与MRS强相关并能区分喉罩与气管插管干预,可能可用于试验设计。

本文为实用气道复苏试验的二次分析,评估无ICU天数(30天内存活且不在ICU的天数)和无呼吸机天数作为OHCA试验候选结局的效用与有效性。无ICU天数中位数0天(IQR 0,0),幸存者仅24(18,27)天;无呼吸机天数中位数0天(IQR 0,0),幸存者仅27(IQR 23,28)天;两者与MRS相关(Spearman ρ=-0.95和-0.97)。喉罩(LT)在t检验、WRS、CPH和CRR中与更高的无ICU天数相关,在t检验、WRS和CRR中与更高的无呼吸机天数相关,但NB模型无统计学意义。模拟提示t检验和WRS检测 observed 差异的把握度最大。作者认为无ICU天数和无呼吸机天数可能可用于OHCA试验设计。

要点

  • 无ICU天数中位数0天(IQR 0,0),幸存者仅24(18,27)天;无呼吸机天数中位数0天(IQR 0,0),幸存者仅27(IQR 23,28)天。
  • 无ICU天数与MRS的Spearman相关系数ρ=-0.95,无呼吸机天数与MRS的ρ=-0.97。
  • 喉罩(LT)与更高无ICU天数相关:t检验p=0.001、WRS p=0.003、CPH p=0.02、CRR p=0.04,但NB模型p=0.13。
  • 喉罩(LT)与更高无呼吸机天数相关:t检验p=0.001、WRS p=0.001、CRR p=0.03,但NB模型p=0.13、CPH p=0.13。
  • 模拟提示t检验和WRS对检测 observed 的无ICU天数和无呼吸机天数差异把握度最大。

适用人群与场景

  • 院外心脏骤停(OHCA)患者,来自实用气道复苏试验的二次分析人群。

诊断标准与关键阈值

  • 无ICU天数:30天内存活且不在ICU的天数;无呼吸机天数:存活且未接受机械通气的天数。

研究设计与关键结果

  • 研究类型:实用气道复苏试验的二次分析;干预:喉罩(LT)与气管插管(ETI)比较;主要终点:无ICU天数和无呼吸机天数。
  • 无ICU天数呈偏态分布,中位数0天(IQR 0,0),幸存者仅24(18,27)天;无呼吸机天数呈偏态分布,中位数0天(IQR 0,0),幸存者仅27(IQR 23,28)天。
  • 无ICU天数与MRS相关(Spearman ρ=-0.95),无呼吸机天数与MRS相关(Spearman ρ=-0.97)。
  • LT与更高无ICU天数相关:t检验p=0.001,WRS p=0.003,CPH p=0.02,CRR p=0.04,但NB模型p=0.13。
  • LT与更高无呼吸机天数相关:t检验p=0.001,WRS p=0.001,CRR p=0.03,但NB模型p=0.13,CPH p=0.13。
  • 模拟提示t检验和WRS对检测 observed 的无ICU天数和无呼吸机天数差异把握度最大。

证据类型、等级与局限

  • 证据类型:实用气道复苏试验的二次分析;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为无ICU天数和无呼吸机天数可能可用于OHCA试验设计。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: We sought to evaluate the utility and validity of ICU-free days and ventilator-free days as candidate outcomes for OHCA trials.

METHODS: We conducted a secondary analysis of the Pragmatic Airway Resuscitation Trial. We determined ICU-free (days alive and out of ICU during the first 30 days) and ventilator-free days (days alive and without mechanical ventilation). We determined ICU-free and ventilator-free day distributions and correlations with Modified Rankin Scale (MRS). We tested associations with trial interventions (laryngeal tube (LT), endotracheal intubation (ETI)) using continuous (t-test), non-parametric (Wilcoxon Rank-Sum test - WRS), count (negative binomial - NB) and survival models (Cox proportional hazards (CPH) and competing risks regression (CRR)). We conducted bootstrapped simulations to estimate statistical power.

MAIN RESULTS: ICU-free days was skewed; median 0 days (IQR 0, 0), survivors only 24 (18, 27). Ventilator-free days was skewed; median 0 (IQR 0, 0) days, survivors only 27 (IQR 23, 28). ICU-free and ventilator-free days correlated with MRS (Spearman's ρ = -0.95 and -0.97). LT was associated with higher ICU-free days using t-test (p = 0.001), WRS (p = 0.003), CPH (p = 0.02) and CRR (p = 0.04), but not NB (p = 0.13). LT was associated with higher ventilator-free days using t-test (p = 0.001), WRS (p = 0.001) and CRR (p = 0.03), but not NB (p = 0.13) or CPH (p = 0.13). Simulations suggested that t-test and WRS would have had the greatest power to detect the observed ICU- and ventilator-free days differences.

CONCLUSION: ICU-free and ventilator-free days correlated with MRS and differentiated trial interventions. ICU-free and ventilator-free days may have utility in the design of OHCA trials.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Wang HE, Panchal A, Madison Hyer J, et al. Assessment of intensive care unit-free and ventilator-free days as alternative outcomes in the pragmatic airway resuscitation trial. Resuscitation. 2022. PMID: 35940492. doi:10.1016/j.resuscitation.2022.07.042

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。